Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Angiotensin II Antagonism of TGF-Beta 1
This study has been completed.
Study NCT00320970.   Last updated on August 1, 2007.
Information provided by Providence Health Care
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Hypertension
Additional conditions recognized in this trial
Diabetic Nephropathies
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Kidney Diseases
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
Candesartan
Additional drug interventions recognized in this trial
Angiotensin II
Candesartan cilexetil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Providence Health Care
AstraZeneca


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services